ASIX logo

AdvanSix Inc. Stock Price

NYSE:ASIX Community·US$546.1m Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

ASIX Share Price Performance

US$20.32
-3.89 (-16.07%)
US$23.50
Fair Value
US$20.32
-3.89 (-16.07%)
13.5% undervalued intrinsic discount
US$23.50
Fair Value
Price US$20.32
AnalystConsensusTarget US$23.50
woodworthfund US$32.00
AnalystHighTarget US$27.00

ASIX Community Narratives

·
Fair Value US$23.5 13.5% undervalued intrinsic discount

Ammonium Sulfate Expansion And Tax Credits Will Strengthen Future Earnings Stability

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
Fair Value
·
Fair Value US$32 36.5% undervalued intrinsic discount

THE CHEMISTRY OF MISPRICING: WHY ADVANSIX (ASIX) IS A "DOLLAR FOR 50 CENTS"

1users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$27 24.7% undervalued intrinsic discount

Cost Savings And Fertilizer Demand Tailwinds Will Support Stronger Future Potential

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$32
36.5% undervalued intrinsic discount
Fair Value
Revenue
25.98% p.a.
Profit Margin
3.52%
Future PE
8.22x
Price in 2031
US$50.45
US$23.5
13.5% undervalued intrinsic discount
Revenue
3.37% p.a.
Profit Margin
4.2%
Future PE
11.45x
Price in 2029
US$29.85
US$20
1.6% overvalued intrinsic discount
Revenue
3.03% p.a.
Profit Margin
4.39%
Future PE
9.43x
Price in 2029
US$25.45
US$27
24.7% undervalued intrinsic discount
Revenue
4.26% p.a.
Profit Margin
4.21%
Future PE
12.81x
Price in 2029
US$34.37

Trending Discussion

Updated Narratives

ASIX logo

THE CHEMISTRY OF MISPRICING: WHY ADVANSIX (ASIX) IS A "DOLLAR FOR 50 CENTS"

Fair Value: US$32 36.5% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ASIX logo

ASIX: Cost Discipline And Nutrients Outlook Will Counter Input Cost Pressures

Fair Value: US$23.5 13.5% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ASIX logo

High Sulfur Costs And Nylon Weakness Will Pressure Margins For Years

Fair Value: US$20 1.6% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and fair value.

3 Risks
2 Rewards

AdvanSix Inc. Key Details

US$1.5b

Revenue

US$1.4b

Cost of Revenue

US$141.3m

Gross Profit

US$130.9m

Other Expenses

US$10.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.39
9.12%
0.67%
33.9%
View Full Analysis

About ASIX

Founded
2016
Employees
1410
CEO
Erin Kane
WebsiteView website
www.advansix.com

AdvanSix Inc., integrated chemistry company, engages in the manufacture and sale of polymer resins in the United States and internationally. The company offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. It also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and resins. In addition, the company offers intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines; and cyclohexanol, sulfuric acid, ammonia, and carbon dioxide, as well as automotive components, water treatment, and pharmaceutical intermediates. It offers its products under the Aegis, Sulf-N, Nadone, Naxol, and EZ-Blox under brand names. The company sells its products directly and through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.

Recent ASIX News & Updates

Narrative Update Apr 27

ASIX: Cost Discipline And Nutrients Outlook Will Counter Input Cost Pressures

Analysts have nudged their price target on AdvanSix up by $1 to $20, citing near term pressure from higher input costs, along with expectations that ongoing cost and capital spending rationalization could support positive free cash flow in 2026, despite anticipated year over year EBITDA pressure. Analyst Commentary Recent commentary around AdvanSix reflects a mix of cautious near term views and more constructive longer term expectations tied to cash generation and capital discipline.

Recent updates

No updates